Showing results (111-120 of 239) with videos related to

Sort By:
Pageof 24
Nature Medicine|July 30, 1999
Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferonM Cella, D Jarrossay, F Facchetti, et al.
Mucosal Immunology|November 10, 2016
Microbiota induces tonic CCL2 systemic levels that control pDC trafficking in steady stateM Swiecki, H L Miller, R Sesti-Costa, et al.
The Journal of Experimental Medicine|May 19, 1997
A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processingM Cella, C Döhring, J Samaridis, et al.
European Journal of Immunology|February 5, 1999
The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cellsF Navarro, M Llano, T Bellón, et al.
Bulletin Du Cancer|February 1, 1997
[Prevalence assessment of colorectal and breast cancers in the Rhône-Alpes area]M Colonna, F Ménégoz, C Exbrayat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 5, 2010
Breast cancer incidence and time trend in France from 1990 to 2007: a population-based study from two French cancer registriesL Daubisse-Marliac, P Delafosse, J B Boitard, et al.
Thescientificworldjournal|November 4, 2004
Spinal cord blood flow after ischemic preconditioning in a rat model of spinal cord ischemiaDavid Zvara, James M Zboyovski, Dwight D Deal, et al.
Intensive Care Medicine|December 1, 1996
Severe head injuries: an outcome prediction and survival analysisP Combes, B Fauvage, M Colonna, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 19, 2002
Measuring cancer prevalence in Europe: the EUROPREVAL projectR Capocaccia, M Colonna, I Corazziari, et al.
Cancer Epidemiology|August 21, 2018
Time trends and short term projections of cancer prevalence in FranceM Colonna, O Boussari, A Cowppli-Bony, et al.
Pageof 24